According to the Hygiene Institute's Health Information Center, the number of deaths from diabetes mellitus complications in Lithuania has almost doubled during the past decade.
According to Violetė Bičkauskienė, a diabetic physician at Santaros Clinic, this can be caused by insufficient care in diabetic care, which is heavily dependent on the patient's own commitment, according to a press release in the media.
"The treatment of a diabetic patient is complex and its efficacy is determined not only by the latest treatment methods. Patients must perform self-monitoring, monitor the disease continuously and carry out the analysis so it is important not to be afraid to contact appropriate specialists who can learn it," says V. Bickkauskienė.
Diabetic teacher – Nurse diabetic working in the health care – Advice from a family doctor for diabetes in Lithuania for several years already.
They help to focus on what and why the patient is discussing the causes of glucose fluctuations, the importance of self control and everything related to diabetes in human life.
The patients themselves should be vigilant
Many patients with type 2 diabetes receive insulin, why they, like those with type 1 diabetes, are particularly interested in understanding how to adjust their doses themselves, as this should happen continuously.
When initiating the patient's insulin treatment, the first three months determine what will be the control in recent years. Failure to achieve the indicators required at the start of treatment will reduce their chances of reaching them in the future, and the patient should therefore be involved in patient care initially.
"Based on glucose measurements, when assessing the amount of carbohydrates in a meal, the patient should consider how much insulin should be taken. Each body's sensitivity to insulin is different. Therefore, insulin doses for the same food are also chosen individually," says the nurse.
By calculating carbohydrates and choosing your own insulin dose, patients will not only delay the complications of the disease but also directly affect the outcome of the treatment of diabetes.
Improved glycemic control can reduce the risk of cardiovascular disease by as much as 25%. over a period of 10 years.
Why are patients afraid to increase the insulin dose?
Optimal blood glucose levels are often hampered by the insufficient dose of insulin. Previously, insulin therapy has been associated with hypoglycaemia, excessive glucose levels and increased body weight gain, and patients were reluctant to increase the dose.
Nowadays, patients are increasingly being treated with the new generation of basal insulins, which not only show longer and more fair effects but also more in line with human physiology, reduces the incidence of hypoglycaemia and has a lower effect on the patient's body weight.
When tablet treatment is no longer effective, basal insulin is the first drug in the latest European and American diabetes management guidelines because mixed insulin in both syringes containing both basal and food insulin may increase the risk of hypoglycaemia and weight gain.